Page last updated: 2024-12-06

sodium chromate(vi)

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

sodium chromate(VI): RN given refers to cpd with (MF) CR-H2-O4.Na [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

sodium chromate : An inorganic sodium salt consisting of sodium and chromate ions in a 2:1 ratio. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID24488
CHEBI ID78671
MeSH IDM0092792

Synonyms (34)

Synonym
sodium chromate
einecs 231-889-5
chromic acid, disodium salt
disodium chromate
epa pesticide chemical code 068303
chromic acid (h2cro4), disodium salt
hsdb 2962
ccris 883
ccris 6100
chromate of soda
chromium disodium oxide
caswell no. 757
chromic acid, disodium salt, tetrahydrate
neutral sodium chromate
sodium chromate(vi)
chromium sodium oxide (crna2o4)
7775-11-3
disodium dioxido(dioxo)chromium
chromic acid (h2cro4), sodium salt (1:2)
ec 231-889-5
unii-c1v2dcl6b1
6a49bo6k4m ,
unii-6a49bo6k4m
chromium sodium oxide
12680-48-7
PXLIDIMHPNPGMH-UHFFFAOYSA-N
sodium monochromate
chromic acid (h2cro4) sodium salt (1:2)
sodium chromate [mi]
CHEBI:78671 ,
chromiumsodium oxide
DTXSID7032056
Q407958
disodium;dioxido(dioxo)chromium

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" CHOR cells were also found to be cross-resistant to the cytotoxicity and DNA breaks caused by other toxic metals such as CdCl2 and HgCl2."( DNA single-strand breaks and cytotoxicity induced by sodium chromate(VI) in hydrogen peroxide-resistant cell lines.
Haramaki, N; Sugiyama, M; Tsuzuki, K, 1993
)
0.54
" The dose necessary for protection against toxic Cr action in adult rats was not tolerated by young rats."( Vitamin E and C in the prevention of metal nephrotoxicity in developing rats.
Appenroth, D; Winnefeld, K, 1998
)
0.3

Bioavailability

ExcerptReferenceRelevance
" DNA adduct formation was monitored as a marker for bioavailability of genotoxic chromium."( Apoptosis and P53 induction in human lung fibroblasts exposed to chromium (VI): effect of ascorbate and tocopherol.
Blankenship, LJ; Carlisle, DL; Orenstein, JM; Owens, BM; Patierno, SR; Pritchard, DE; Singh, J, 2000
)
0.31
" The absorption rate of chromic oxide, which is considered a nonabsorbable compound, was 14."( Absorption of inorganic, trivalent and hexavalent chromium following oral and intrajejunal doses in rats.
Fébel, H; Huszár, S; Szegedi, B, 2001
)
0.31

Dosage Studied

ExcerptRelevanceReference
" Urine was collected for up to 48 hr after dosing and was analyzed by 1H NMR spectroscopy (400 MHz) and conventional biochemical methods to provide biochemical fingerprints of urine in various site-specific nephrotoxic states."( Investigations into the biochemical effects of region-specific nephrotoxins.
Bonner, FW; Gartland, KP; Nicholson, JK, 1989
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
carcinogenic agentA role played by a chemical compound which is known to induce a process of carcinogenesis by corrupting normal cellular pathways, leading to the acquistion of tumoral capabilities.
oxidising agentA substance that removes electrons from another reactant in a redox reaction.
poisonAny substance that causes disturbance to organisms by chemical reaction or other activity on the molecular scale, when a sufficient quantity is absorbed by the organism.
diagnostic agentA substance administered to aid diagnosis of a disease.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
inorganic sodium salt
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (151)

TimeframeStudies, This Drug (%)All Drugs %
pre-199073 (48.34)18.7374
1990's39 (25.83)18.2507
2000's31 (20.53)29.6817
2010's7 (4.64)24.3611
2020's1 (0.66)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 16.74

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index16.74 (24.57)
Research Supply Index5.08 (2.92)
Research Growth Index4.19 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (16.74)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.63%)5.53%
Reviews1 (0.63%)6.00%
Case Studies3 (1.89%)4.05%
Observational0 (0.00%)0.25%
Other154 (96.86%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]